Private Wealth Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$615K Sell
3,927
-200
-5% -$30K 0.06% 171
2026
Q1
$630K Hold
4,127
0.07% 153
2025
Q4
$569K Hold
4,127
0.06% 159
2025
Q3
$529K Buy
4,127
+5
+0.1% +$610 0.06% 158
2025
Q2
$499K Hold
4,122
0.07% 159
2025
Q1
$460K Buy
+4,122
New +$439K 0.07% 157

Other funds holding NVS

Private Wealth Asset Management's NVS Position: Q2 2026 in Review

Private Wealth Asset Management reduced its Novartis (NVS) stake by 4.8% in Q2 2026, selling an estimated $30K and leaving 3,927 shares worth $615K. The position accounts for 0.06% of the portfolio, ranked #171.

Private Wealth Asset Management first reported a position in NVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $630K in Q1 2026. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Private Wealth Asset Management held 3,927 shares of Novartis worth $615K as of Q2 2026.
  • Private Wealth Asset Management sold 200 Novartis shares in Q2 2026, an estimated $30K.
  • Novartis made up 0.06% of Private Wealth Asset Management's portfolio in Q2 2026, its #171 holding.
  • Private Wealth Asset Management first reported a position in Novartis in Q1 2025 and has held it in 6 quarters since.
  • Private Wealth Asset Management's Novartis position peaked at $630K in Q1 2026.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.